世界の神経障害診断市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Neurological Disorder Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12503 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、神経障害診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経障害診断の種類別市場規模（画像技術、体外診断技術）、用途別市場規模（病院・クリニック、診断センター、外来診療センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・神経障害診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Siemens、Philips、GE、Esaote、Masimo、Croton Healthcare、Neusoft ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：画像技術、体外診断技術 ・用途別分析2016年-2026年：病院・クリニック、診断センター、外来診療センター ・神経障害診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・神経障害診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・神経障害診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・神経障害診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・神経障害診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Neurological Disorder Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Neurological Disorder Diagnostics size is estimated to be USD 12100 million in 2026 from USD 10370 million in 2020, with a change XX% between 2020 and 2021. The global Neurological Disorder Diagnostics market size is expected to grow at a CAGR of 3.9% for the next five years.

Market segmentation
Neurological Disorder Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Imaging Techniques
In Vitro Diagnostics Techniques

Market segment by Application, can be divided into
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers

Market segment by players, this report covers
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Neurological Disorder Diagnostics
1.2 Classification of Neurological Disorder Diagnostics by Type
1.2.1 Overview: Global Neurological Disorder Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Neurological Disorder Diagnostics Revenue Market Share by Type in 2020
1.2.3 Imaging Techniques
1.2.4 In Vitro Diagnostics Techniques
1.3 Global Neurological Disorder Diagnostics Market by Application
1.3.1 Overview: Global Neurological Disorder Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Care Centers
1.4 Global Neurological Disorder Diagnostics Market Size & Forecast
1.5 Global Neurological Disorder Diagnostics Market Size and Forecast by Region
1.5.1 Global Neurological Disorder Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Neurological Disorder Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Neurological Disorder Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Neurological Disorder Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Neurological Disorder Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Neurological Disorder Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Neurological Disorder Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Neurological Disorder Diagnostics Market Drivers
1.6.2 Neurological Disorder Diagnostics Market Restraints
1.6.3 Neurological Disorder Diagnostics Trends Analysis
2 Company Profiles
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens Neurological Disorder Diagnostics Product and Solutions
2.1.4 Siemens Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Siemens Recent Developments and Future Plans
2.2 Philips
2.2.1 Philips Details
2.2.2 Philips Major Business
2.2.3 Philips Neurological Disorder Diagnostics Product and Solutions
2.2.4 Philips Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Philips Recent Developments and Future Plans
2.3 GE
2.3.1 GE Details
2.3.2 GE Major Business
2.3.3 GE Neurological Disorder Diagnostics Product and Solutions
2.3.4 GE Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GE Recent Developments and Future Plans
2.4 Esaote
2.4.1 Esaote Details
2.4.2 Esaote Major Business
2.4.3 Esaote Neurological Disorder Diagnostics Product and Solutions
2.4.4 Esaote Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Esaote Recent Developments and Future Plans
2.5 Masimo
2.5.1 Masimo Details
2.5.2 Masimo Major Business
2.5.3 Masimo Neurological Disorder Diagnostics Product and Solutions
2.5.4 Masimo Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Masimo Recent Developments and Future Plans
2.6 Croton Healthcare
2.6.1 Croton Healthcare Details
2.6.2 Croton Healthcare Major Business
2.6.3 Croton Healthcare Neurological Disorder Diagnostics Product and Solutions
2.6.4 Croton Healthcare Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Croton Healthcare Recent Developments and Future Plans
2.7 Neusoft
2.7.1 Neusoft Details
2.7.2 Neusoft Major Business
2.7.3 Neusoft Neurological Disorder Diagnostics Product and Solutions
2.7.4 Neusoft Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Neusoft Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neurological Disorder Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Neurological Disorder Diagnostics Players Market Share
3.2.2 Top 10 Neurological Disorder Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Neurological Disorder Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Neurological Disorder Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Neurological Disorder Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Neurological Disorder Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Neurological Disorder Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Neurological Disorder Diagnostics Revenue by Type (2016-2026)
6.2 North America Neurological Disorder Diagnostics Revenue by Application (2016-2026)
6.3 North America Neurological Disorder Diagnostics Market Size by Country
6.3.1 North America Neurological Disorder Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Neurological Disorder Diagnostics Revenue by Type (2016-2026)
7.2 Europe Neurological Disorder Diagnostics Revenue by Application (2016-2026)
7.3 Europe Neurological Disorder Diagnostics Market Size by Country
7.3.1 Europe Neurological Disorder Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Neurological Disorder Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Neurological Disorder Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Neurological Disorder Diagnostics Market Size by Region
8.3.1 Asia-Pacific Neurological Disorder Diagnostics Revenue by Region (2016-2026)
8.3.2 China Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Neurological Disorder Diagnostics Revenue by Type (2016-2026)
9.2 South America Neurological Disorder Diagnostics Revenue by Application (2016-2026)
9.3 South America Neurological Disorder Diagnostics Market Size by Country
9.3.1 South America Neurological Disorder Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Neurological Disorder Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Neurological Disorder Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Country
10.3.1 Middle East & Africa Neurological Disorder Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Neurological Disorder Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Neurological Disorder Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Neurological Disorder Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Neurological Disorder Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Neurological Disorder Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Neurological Disorder Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Siemens Corporate Information, Head Office, and Major Competitors
Table 7. Siemens Major Business
Table 8. Siemens Neurological Disorder Diagnostics Product and Solutions
Table 9. Siemens Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Philips Corporate Information, Head Office, and Major Competitors
Table 11. Philips Major Business
Table 12. Philips Neurological Disorder Diagnostics Product and Solutions
Table 13. Philips Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GE Corporate Information, Head Office, and Major Competitors
Table 15. GE Major Business
Table 16. GE Neurological Disorder Diagnostics Product and Solutions
Table 17. GE Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Esaote Corporate Information, Head Office, and Major Competitors
Table 19. Esaote Major Business
Table 20. Esaote Neurological Disorder Diagnostics Product and Solutions
Table 21. Esaote Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Masimo Corporate Information, Head Office, and Major Competitors
Table 23. Masimo Major Business
Table 24. Masimo Neurological Disorder Diagnostics Product and Solutions
Table 25. Masimo Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Croton Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. Croton Healthcare Major Business
Table 28. Croton Healthcare Neurological Disorder Diagnostics Product and Solutions
Table 29. Croton Healthcare Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Neusoft Corporate Information, Head Office, and Major Competitors
Table 31. Neusoft Major Business
Table 32. Neusoft Neurological Disorder Diagnostics Product and Solutions
Table 33. Neusoft Neurological Disorder Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Neurological Disorder Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 35. Global Neurological Disorder Diagnostics Revenue Share by Players (2019-2021)
Table 36. Breakdown of Neurological Disorder Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Neurological Disorder Diagnostics Players Head Office, Products and Services Provided
Table 38. Neurological Disorder Diagnostics Mergers & Acquisitions in the Past Five Years
Table 39. Neurological Disorder Diagnostics New Entrants and Expansion Plans
Table 40. Global Neurological Disorder Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 41. Global Neurological Disorder Diagnostics Revenue Share by Type (2016-2021)
Table 42. Global Neurological Disorder Diagnostics Revenue Forecast by Type (2021-2026)
Table 43. Global Neurological Disorder Diagnostics Revenue by Application (2016-2021)
Table 44. Global Neurological Disorder Diagnostics Revenue Forecast by Application (2021-2026)
Table 45. North America Neurological Disorder Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Neurological Disorder Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Neurological Disorder Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Neurological Disorder Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Neurological Disorder Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Neurological Disorder Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Neurological Disorder Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Neurological Disorder Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Neurological Disorder Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Neurological Disorder Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Neurological Disorder Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Neurological Disorder Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Neurological Disorder Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Neurological Disorder Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Neurological Disorder Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Neurological Disorder Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Neurological Disorder Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Neurological Disorder Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Neurological Disorder Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Neurological Disorder Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Neurological Disorder Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Neurological Disorder Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Neurological Disorder Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Neurological Disorder Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Neurological Disorder Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Neurological Disorder Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Neurological Disorder Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Neurological Disorder Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Neurological Disorder Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Neurological Disorder Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Neurological Disorder Diagnostics Picture
Figure 2. Global Neurological Disorder Diagnostics Revenue Market Share by Type in 2020
Figure 3. Imaging Techniques
Figure 4. In Vitro Diagnostics Techniques
Figure 5. Neurological Disorder Diagnostics Revenue Market Share by Application in 2020
Figure 6. Hospitals and Clinics Picture
Figure 7. Diagnostic Centers Picture
Figure 8. Ambulatory Care Centers Picture
Figure 9. Global Neurological Disorder Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Neurological Disorder Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Neurological Disorder Diagnostics Revenue Market Share by Region (2016-2026)
Figure 12. Global Neurological Disorder Diagnostics Revenue Market Share by Region in 2020
Figure 13. North America Neurological Disorder Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Neurological Disorder Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Neurological Disorder Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Neurological Disorder Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Neurological Disorder Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Neurological Disorder Diagnostics Market Drivers
Figure 19. Neurological Disorder Diagnostics Market Restraints
Figure 20. Neurological Disorder Diagnostics Market Trends
Figure 21. Siemens Recent Developments and Future Plans
Figure 22. Philips Recent Developments and Future Plans
Figure 23. GE Recent Developments and Future Plans
Figure 24. Esaote Recent Developments and Future Plans
Figure 25. Masimo Recent Developments and Future Plans
Figure 26. Croton Healthcare Recent Developments and Future Plans
Figure 27. Neusoft Recent Developments and Future Plans
Figure 28. Global Neurological Disorder Diagnostics Revenue Share by Players in 2020
Figure 29. Neurological Disorder Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Neurological Disorder Diagnostics Revenue Market Share in 2020
Figure 31. Global Top 10 Players Neurological Disorder Diagnostics Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Neurological Disorder Diagnostics Revenue Share by Type in 2020
Figure 34. Global Neurological Disorder Diagnostics Market Share Forecast by Type (2021-2026)
Figure 35. Global Neurological Disorder Diagnostics Revenue Share by Application in 2020
Figure 36. Global Neurological Disorder Diagnostics Market Share Forecast by Application (2021-2026)
Figure 37. North America Neurological Disorder Diagnostics Sales Market Share by Type (2016-2026)
Figure 38. North America Neurological Disorder Diagnostics Sales Market Share by Application (2016-2026)
Figure 39. North America Neurological Disorder Diagnostics Revenue Market Share by Country (2016-2026)
Figure 40. United States Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Neurological Disorder Diagnostics Sales Market Share by Type (2016-2026)
Figure 44. Europe Neurological Disorder Diagnostics Sales Market Share by Application (2016-2026)
Figure 45. Europe Neurological Disorder Diagnostics Revenue Market Share by Country (2016-2026)
Figure 46. Germany Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Neurological Disorder Diagnostics Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Neurological Disorder Diagnostics Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Neurological Disorder Diagnostics Revenue Market Share by Region (2016-2026)
Figure 54. China Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Neurological Disorder Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. South America Neurological Disorder Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. South America Neurological Disorder Diagnostics Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Neurological Disorder Diagnostics Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Neurological Disorder Diagnostics Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Neurological Disorder Diagnostics Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Neurological Disorder Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source

---